Literature DB >> 24733099

Epidemic Clostridium difficile strains demonstrate increased competitive fitness compared to nonepidemic isolates.

Catherine D Robinson1, Jennifer M Auchtung1, James Collins1, Robert A Britton2.   

Abstract

Clostridium difficile infection is the most common cause of severe cases of antibiotic-associated diarrhea (AAD) and is a significant health burden. Recent increases in the rate of C. difficile infection have paralleled the emergence of a specific phylogenetic clade of C. difficile strains (ribotype 027; North American pulsed-field electrophoresis 1 [NAP1]; restriction endonuclease analysis [REA] group BI). Initial reports indicated that ribotype 027 strains were associated with increased morbidity and mortality and might be hypervirulent. Although subsequent work has raised some doubt as to whether ribotype 027 strains are hypervirulent, the strains are considered epidemic isolates that have caused severe outbreaks across the globe. We hypothesized that one factor that could lead to the increased prevalence of ribotype 027 strains would be if these strains had increased competitive fitness compared to strains of other ribotypes. We developed a moderate-throughput in vitro model of C. difficile infection and used it to test competition between four ribotype 027 clinical isolates and clinical isolates of four other ribotypes (001, 002, 014, and 053). We found that ribotype 027 strains outcompeted the strains of other ribotypes. A similar competitive advantage was observed when two ribotype pairs were competed in a mouse model of C. difficile infection. Based upon these results, we conclude that one possible mechanism through which ribotype 027 strains have caused outbreaks worldwide is their increased ability to compete in the presence of a complex microbiota.
Copyright © 2014, American Society for Microbiology. All Rights Reserved.

Entities:  

Mesh:

Substances:

Year:  2014        PMID: 24733099      PMCID: PMC4097623          DOI: 10.1128/IAI.01524-14

Source DB:  PubMed          Journal:  Infect Immun        ISSN: 0019-9567            Impact factor:   3.441


  51 in total

1.  Microbial community development in a dynamic gut model is reproducible, colon region specific, and selective for Bacteroidetes and Clostridium cluster IX.

Authors:  Pieter Van den Abbeele; Charlotte Grootaert; Massimo Marzorati; Sam Possemiers; Willy Verstraete; Philippe Gérard; Sylvie Rabot; Aurélia Bruneau; Sahar El Aidy; Muriel Derrien; Erwin Zoetendal; Michiel Kleerebezem; Hauke Smidt; Tom Van de Wiele
Journal:  Appl Environ Microbiol       Date:  2010-06-18       Impact factor: 4.792

2.  Mortality attributable to nosocomial Clostridium difficile-associated disease during an epidemic caused by a hypervirulent strain in Quebec.

Authors:  Jacques Pépin; Louis Valiquette; Benoit Cossette
Journal:  CMAJ       Date:  2005-09-22       Impact factor: 8.262

3.  Flavin-dependent thymidylate synthase X limits chromosomal DNA replication.

Authors:  Frédéric Escartin; Stéphane Skouloubris; Ursula Liebl; Hannu Myllykallio
Journal:  Proc Natl Acad Sci U S A       Date:  2008-07-11       Impact factor: 11.205

4.  Assessing and improving methods used in operational taxonomic unit-based approaches for 16S rRNA gene sequence analysis.

Authors:  Patrick D Schloss; Sarah L Westcott
Journal:  Appl Environ Microbiol       Date:  2011-03-18       Impact factor: 4.792

5.  Frequency of antibiotic-associated diarrhoea in 2462 antibiotic-treated hospitalized patients: a prospective study.

Authors:  J Wiström; S R Norrby; E B Myhre; S Eriksson; G Granström; L Lagergren; G Englund; C E Nord; B Svenungsson
Journal:  J Antimicrob Chemother       Date:  2001-01       Impact factor: 5.790

6.  Health care-associated Clostridium difficile infection in Canada: patient age and infecting strain type are highly predictive of severe outcome and mortality.

Authors:  Mark Miller; Denise Gravel; Michael Mulvey; Geoffrey Taylor; David Boyd; Andrew Simor; Michael Gardam; Allison McGeer; James Hutchinson; Dorothy Moore; Sharon Kelly
Journal:  Clin Infect Dis       Date:  2010-01-15       Impact factor: 9.079

7.  Comparison of the burdens of hospital-onset, healthcare facility-associated Clostridium difficile Infection and of healthcare-associated infection due to methicillin-resistant Staphylococcus aureus in community hospitals.

Authors:  Becky A Miller; Luke F Chen; Daniel J Sexton; Deverick J Anderson
Journal:  Infect Control Hosp Epidemiol       Date:  2011-04       Impact factor: 3.254

8.  Detection of mixed populations of Clostridium difficile from symptomatic patients using capillary-based polymerase chain reaction ribotyping.

Authors:  Adam A Behroozian; Jeffrey P Chludzinski; Eugene S Lo; Sarah A Ewing; Sheila Waslawski; Duane W Newton; Vincent B Young; David M Aronoff; Seth T Walk
Journal:  Infect Control Hosp Epidemiol       Date:  2013-07-12       Impact factor: 3.254

9.  Reproducible community dynamics of the gastrointestinal microbiota following antibiotic perturbation.

Authors:  Dionysios A Antonopoulos; Susan M Huse; Hilary G Morrison; Thomas M Schmidt; Mitchell L Sogin; Vincent B Young
Journal:  Infect Immun       Date:  2009-03-23       Impact factor: 3.441

10.  Statistical methods for detecting differentially abundant features in clinical metagenomic samples.

Authors:  James Robert White; Niranjan Nagarajan; Mihai Pop
Journal:  PLoS Comput Biol       Date:  2009-04-10       Impact factor: 4.475

View more
  24 in total

Review 1.  The upcoming 3D-printing revolution in microfluidics.

Authors:  Nirveek Bhattacharjee; Arturo Urrios; Shawn Kang; Albert Folch
Journal:  Lab Chip       Date:  2016-04-21       Impact factor: 6.799

Review 2.  Interactions Between the Gastrointestinal Microbiome and Clostridium difficile.

Authors:  Casey M Theriot; Vincent B Young
Journal:  Annu Rev Microbiol       Date:  2015       Impact factor: 15.500

Review 3.  Control of Clostridium difficile Infection by Defined Microbial Communities.

Authors:  James Collins; Jennifer M Auchtung
Journal:  Microbiol Spectr       Date:  2017-09

4.  The Mini Colon Model: a benchtop multi-bioreactor system to investigate the gut microbiome.

Authors:  Zijie Jin; Andy Ng; Corinne F Maurice; David Juncker
Journal:  Gut Microbes       Date:  2022 Jan-Dec

5.  MiniBioReactor Array (MBRA) in vitro gut model: a reliable system to study microbiota-dependent response to antibiotic treatment.

Authors:  C A Hobson; L Vigue; S Naimi; B Chassaing; M Magnan; S Bonacorsi; B Gachet; I El Meouche; A Birgy; O Tenaillon
Journal:  JAC Antimicrob Resist       Date:  2022-07-05

6.  Mucin-Degrading Microbes Release Monosaccharides That Chemoattract Clostridioides difficile and Facilitate Colonization of the Human Intestinal Mucus Layer.

Authors:  Melinda A Engevik; Amy C Engevik; Kristen A Engevik; Jennifer M Auchtung; Alexandra L Chang-Graham; Wenly Ruan; Ruth Ann Luna; Joseph M Hyser; Jennifer K Spinler; James Versalovic
Journal:  ACS Infect Dis       Date:  2020-11-11       Impact factor: 5.084

Review 7.  Microbiome and metabolome data integration provides insight into health and disease.

Authors:  Michael Shaffer; Abigail J S Armstrong; Vanessa V Phelan; Nichole Reisdorph; Catherine A Lozupone
Journal:  Transl Res       Date:  2017-07-14       Impact factor: 7.012

8.  Next-Generation Probiotics Targeting Clostridium difficile through Precursor-Directed Antimicrobial Biosynthesis.

Authors:  Jennifer K Spinler; Jennifer Auchtung; Aaron Brown; Prapaporn Boonma; Numan Oezguen; Caná L Ross; Ruth Ann Luna; Jessica Runge; James Versalovic; Alex Peniche; Sara M Dann; Robert A Britton; Anthony Haag; Tor C Savidge
Journal:  Infect Immun       Date:  2017-09-20       Impact factor: 3.441

Review 9.  Integrating Systems and Synthetic Biology to Understand and Engineer Microbiomes.

Authors:  Patrick A Leggieri; Yiyi Liu; Madeline Hayes; Bryce Connors; Susanna Seppälä; Michelle A O'Malley; Ophelia S Venturelli
Journal:  Annu Rev Biomed Eng       Date:  2021-03-29       Impact factor: 9.590

10.  Fusobacteriumnucleatum Adheres to Clostridioides difficile via the RadD Adhesin to Enhance Biofilm Formation in Intestinal Mucus.

Authors:  Melinda A Engevik; Heather A Danhof; Jennifer Auchtung; Bradley T Endres; Wenly Ruan; Eugénie Bassères; Amy C Engevik; Qinglong Wu; Maribeth Nicholson; Ruth Ann Luna; Kevin W Garey; Sue E Crawford; Mary K Estes; Renate Lux; Mary Beth Yacyshyn; Bruce Yacyshyn; Tor Savidge; Robert A Britton; James Versalovic
Journal:  Gastroenterology       Date:  2020-11-21       Impact factor: 22.682

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.